Michael Mason, EVP, CFO & Treasurer at Karyopharm Therapeutics Inc. (KPTI), sold 33,849 shares at $1.20 ($40K) on 2024-03-01, disclosed to the SEC on 2024-03-04.
Seasonal sale ($40k) by EVP, CFO & Treasurer — this insider has traded KPTI in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 27,687 | $32K | 81.4% |
| 2 | $1.20 | 6,162 | $7K | 18.6% |
| Total | $1.18 avg | 33,849 | $40K | 100% |
| Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |
| KPTI | SELL | 2023-09-05 | $9K | — | Filing → |